Dr. David Bernard Miklos M.D., PH. D.
Hematologist-Oncologist | Hematology & Oncology
300 Pasteur Dr Stanford CA, 94305About
Dr. David Miklos is a hematologist oncologist practicing in Stanford, CA. Dr. Miklos specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Yale School of Medicine 1995
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Renal pathology in hematopoietic cell transplantation recipients.
- H-Y antibody development associates with acute rejection in female patients with male kidney transplants.
- B cells and transplantation: an educational resource.
- Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures.
- Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients.
- Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation.
- Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing.
- Rituximab in hematopoietic cell transplantation.
- Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements.
- Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular remission in high-risk chronic lymphocytic leukaemia.
- Protein microarrays discover angiotensinogen and PRKRIP1 as novel targets for autoantibodies in chronic renal disease.
- Clonally identical Hodgkin's disease develops after allogeneic hematopoietic cell transplant for CLL.
- Recombinant antigen microarrays for serum/plasma antibody detection.
- A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.
- High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment.
Treatments
- Acute Myeloid Leukemia (aml)
- Lymphoma
- Multiple Myeloma
- Leukemia
- Dermal Aesthetics
- Extra Corporeal Shockwave Therapy
Fellowships
- Dana Farber Cancer Institute 2001
Publications
- BLOODA distinct evolution of the T2013
- PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMH-Y antigen-binding B cells develop in male recipients of female hematopoietic cells2013
- PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMHigh-throughput VDJ sequencing for quantification of minimal residual disease in chronic2011
- SCIENCE TRANSLATIOL MEDICINEMeasurement and Clinical Monitoring of Human Lymphocyte Clolity by Massively Parallel V-D2009
- BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONBirth Order and Transplantation Outcome in HLA-Identical Sibling Stem Cell Transplantation2013
- BONE MARROW TRANSPLANTATIONClolly identical Hodgkin's disease develops after allogeneic hematopoietic cell transplant for CLL2011
- BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONThe Outcomes of Family Haploidentical Hematopoietic Stem Cell Transplantation2011
- TURE MEDICINEB cells promote insulin resistance through modulation of T cells2011
- BONE MARROW TRANSPLANTATIONLong-term outcomes in patients with high2011
- Methods in molecular biology (Clifton, N.J.)Recombint antigen microarrays for serum/plasma antibody detection.2011
- BRITISH JOURL OF HAEMATOLOGYComplete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular2010
- Proceedings of the tiol Academy of Sciences of the United States of AmAllogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation.2010
- JOURL OF IMMUNOLOGYIndividual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene2010
- PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMIdentifying compartment-specific non2009
- BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONB Cells and Transplantation: An Educatiol Resource2009
- MODERN PATHOLOGYRel pathology in hematopoietic cell transplantation recipients2008
- BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONToward biomarkers for chronic graft-versus-host disease2006
- LEUKEMIAMinimal residual disease quantification using consensus primers2013
- BLOODA distinct evolution of the T2013
- PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OH-Y antigen-binding B cells develop in male recipients of female hematopoietic cells2013
- BLOODMassive evolution of the immunoglobulin heavy chain locus2012
- BLOODProphylactic rituximab after allogeneic transplantation decreases B2012
- PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OHigh-throughput VDJ sequencing for quantification of minimal residual disease in chronic2011
- SCIENCE TRANSLATIONAL MEDICINEMeasurement and Clinical Monitoring of Human Lymphocyte Clonality by Massively Parallel V-D2009
- BLOODAntibody responses to H-Y minor histocompatibility antigens correlate with chronic graft2005
- BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONBirth Order and Transplantation Outcome in HLA-Identical Sibling Stem Cell Transplantation2013
- VIRAL IMMUNOLOGYHumoral Immunity to Cytomegalovirus and Chronic Graft-Versus-Host Disease2012
- BONE MARROW TRANSPLANTATIONSirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative2012
- BONE MARROW TRANSPLANTATIONClonally identical Hodgkin's dise2011
- BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONAdoptive Immunotherapy with Cytokine2011
- BLOODA phase 1 study of imatinib for corticosteroid-dependent2011
- TRANSPLANTATIONCombined CD4 T-Cell2011
- BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONThe Outcomes of Family Haploidentical Hematopoietic Stem Cell Transplantation2011
- NATURE MEDICINEB cells promote insulin resistance through modulation of T cells2011
- MOLECULAR & CELLULAR PROTEOMICSProtein Microarrays Discover Angiotensinogen2011
- BONE MARROW TRANSPLANTATIONLong-term outcomes in patients with high2011
- Methods in molecular biology (Clifton, N.J.)Recombinant antigen microarrays for serum/plasma antibody detection.2011
- BLOODOutcomes of pediatric bone marrow transplantation for leukemia2010
- HUMAN REPRODUCTIONH-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients2010
- BRITISH JOURNAL OF HAEMATOLOGYComplete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular2010
- Proceedings of the National Academy of Sciences of the United States oAllogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation.2010
- BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONPhase I/II Trial of GN-BVC2010
- JOURNAL OF IMMUNOLOGYIndividual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene2010
- EXPERT OPINION ON BIOLOGICAL THERAPYRituximab in hematopoietic cell transplantation2010
- BLOODAntibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation2010
- BLOODTLI and ATG conditioning with low risk of graft-versus2009
- PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OIdentifying compartment-specific non2009
- BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONB Cells and Transplantation: An Educational Resource2009
- TRANSPLANTATIONH-Y antibody development associates with acute rejection in female patients with male kidney2008
- MODERN PATHOLOGYRenal pathology in hematopoietic cell transplantation recipients2008
- BLOODRituximab for steroid-refractory chronic graft-versus-host disease2006
- BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONToward biomarkers for chronic graft-versus-host disease2006
- BLOODAntibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell2004
Experience & Accolades
- Assistant Professor of Medicine (Blood and Marrow Transplantation)the Stanford University Medical Center
Dr. David Bernard Miklos M.D., PH. D.'s Practice location
Dr. David Bernard Miklos M.D., PH. D.'s reviews
Write ReviewPatient Experience with Dr. Miklos
Recommended Articles
- Morphos Declared a "Breakthrough Therapy" for Lymphoma
MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
- What Specialists Treat Multiple Myeloma?
If you suffer from multiple myeloma, which a rare form of blood cancer, one of the most crucial decisions you will have to make is choosing a doctor who specializes in multiple myeloma. A hematologist-oncologist is the specialist you need who will manage your cancer throughout the cycle of...
- Arizona Firefighters Raise Funds for Lymphoma Stairclimb
Jackson County Fire District #5 partnered with Dutch Bros. Coffee in Phoenix, Arizona to help raise funds for the Leukemia & Lymphoma Society’s Scott Firefighter Stairclimb in Seattle, which took place at the Columbia Center on March 11th, 2018. All of the money raised for the stairclimb go to...
- Touchdown For Lymphoma: Two Teams Put Rivalry Aside For a Cause
Everyone knows that some rivalries can get pretty heated - especially when sports are involved. However, two football teams recognize that there is something more important - supporting a girl with Hodgkin's lymphoma. Although she was a cheerleader for the football team, they are now turning the...
- The Link Between Melatonin and Lymphoma
There’s always room for improvement when it comes to the experience and outcomes of cancer treatment. Fortunately, scientists are constantly researching new, better ways to do so. Although standard treatment remains mostly the same for now, the medical community is making great strides in...
- Schools Join the Fight Against Lymphoma and Blood Cancers
Students at St. Paul Catholic School in Weirton, West Virginia have made their mark in the battle against cancer. By participating in a Student Series program hosted by the Leukemia and Lymphoma Society, students were able to raise $2,006.93 and donate the proceeds to discovering a cure for...
Nearby Providers
- Dr. Joseph Andrew Mollick M.D.875 Blake Wilbur Drive, Mc5820 Stanford CA 94305
- Dr. Alexander Dimitrios Colevas MD875 Blake Wilbur Drive Stanford CA 94305
- Dr. Saul Rosenberg M.D.269 Campus Dr Stanford CA 94305
- Dr. Wen-kai Weng M.D., PH.D.300 Pasteur Dr Stanford CA 94305
- Dr. Hanlee P Ji M.D.875 Blake Wilbur Drive Stanford CA 94305
- Dr. Arash Ash Alizadeh MD, PHD875 Blake Wilbur Drive Stanford CA 94305